PF-07328948 is named as a drug or biological intervention in 3 clinical trials in our USA, UK and China trial registers, 3 of which are recruiting. The lead sponsor is Pfizer. Registered phases: Phase 1 and Phase 2. Conditions studied include Healthy; Heart Failure; Hepatic Impairment.
| NCT ID | Study | Phase | Status |
|---|---|---|---|
| NCT06991257 | A Study to Learn About the Study Medicine Called PF-07328948 in Adults With Heart Failure (BRANCH-HF) (ClinicalTrials.gov ↗) Heart Failure |
Phase 2 | Recruiting |
| NCT07269301 | A Study to Learn How the Body Processes the Study Medicine PF-07328948 in People With and Without Reduced Liver Function (ClinicalTrials.gov ↗) Hepatic Impairment, Healthy |
Phase 1 | Recruiting |
| NCT07315360 | A Study to Learn How the Body Processes the Study Medicine PF-07328948 in People With Reduced Kidney Function (ClinicalTrials.gov ↗) Renal Impairment, Healthy |
Phase 1 | Recruiting |
Registers list studies that are recruiting, about to open, active but closed to enrolment, or enrolling by invitation. The UK and USA registers cover industry-sponsored studies only. Trial titles and statuses are copied from the registry as published.
| Condition (as registered) | Trials |
|---|---|
| Healthy | 2 |
| Heart Failure | 1 |
| Hepatic Impairment | 1 |
| Renal Impairment | 1 |
| Lead sponsor | Trials |
|---|---|
| Pfizer | 3 |
| Register | PF-07328948 trials |
|---|---|
| Clinical trials in USA | 3 |
| Clinical trials in UK | 1 |
| Clinical trials in China | 1 |
A trial with sites in more than one country appears in each of those registers.
Everything on this page is copied from public ClinicalTrials.gov registry records — it is not written from memory, and nothing here describes how PF-07328948 works or whether it is effective. Each trial links to its own record so you can check it yourself.
This page is built automatically: a daily sync job reads the registry records behind our country trial registers, collects every trial that lists PF-07328948 (or a registered synonym) as a drug or biological intervention, and tabulates the registry fields directly. Placebos and generic comparators are excluded. There is no AI drafting and no per-compound editorial pass, and the page has not been clinically reviewed. The “last verified” date above is the timestamp of that sync, not a review date. Our general editorial approach is described in our editorial standards and corrections policy. The ClinicalTrials.gov data on this page was last retrieved on 24 Sep 2026.